FIELD: medicine, in particular, oncogynecology. SUBSTANCE: essence of this method resides in measuring content of prolactin in patient's blood serum prior to treatment. If prolactin concentration exceeds 400mm/ml, immediate vulvar carcinoma relapse is to prognosticated. EFFECT: higher accuracy of prognostication.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTION OF RECURRENT VULVAR CANCER I AND II STAGE | 2015 |
|
RU2608508C1 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
| METHOD FOR PREDICTING VULVA CANCER TREATMENT RESULTS | 1998 |
|
RU2153175C1 |
| METHOD FOR PREDICTING GENERALIZATION OF MAMMARY CANCER | 2001 |
|
RU2204836C2 |
| METHOD FOR REMISSION DURATION PREDICTION IN PATIENTS WITH VULVA CANCER | 2016 |
|
RU2624508C1 |
| METHOD FOR PREDICTING COURSE OF TUMOUR PROCESS IN PATIENTS WITH VULVAR CANCER | 2015 |
|
RU2613119C1 |
| METHOD FOR PREDICTION OF RECURRENT CERVICAL CANCER | 2011 |
|
RU2485523C2 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
